The state..... BCAL is now finalising the necessary analytical and clinical validation of BREASTEST
To me that indicates we are at the final stage of the validation which has been ongoing for some time. Recruitment for this commenced in May 2024 so we can assume that its been an ongoing validation from May onwards as new patients are recruited and tested. Recruitment concluded in November 2024 according to their timeline. So we are down to perhaps just a few remaining people for which the validation is necessary, which I guess is a very quick process ( just days using their test procedure?). So the validation process may well conclude before end December ( 2024) as per their previous indicated timeline , with first revenue to commence Q1 2024 (per their timeline).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22058 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 5714 | 1 |
View Market Depth
| Last trade - 16.21pm 23/07/2025 (20 minute delay) ? |
| BDX (ASX) Chart |
Day chart unavailable